Redmond Asset Management, LLC Bria Cell Therapeutics Corp. Transaction History

Redmond Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$3.0 - $8.31 $759 - $2,102	-253 Reduced 0.18%	137,689 $774,000
Q1 2022 May 03, 2022	BUY	$5.91 - $10.14 $4,988 - $8,558	844 Added 0.62%	137,942 $1.4 Million
Q4 2021 Feb 04, 2022	BUY	$7.1 - $10.61 $3,585 - $5,358	505 Added 0.37%	137,098 $1.14 Million
Q3 2021 Oct 22, 2021	BUY	$4.4 - $9.28 $21,392 - $45,119	4,862 Added 3.69%	136,593 $1.11 Million
Q1 2021 May 06, 2021	BUY	$3.15 - $6.17 $414,952 - $812,780	131,731 New	131,731 $508,000

Ticker BCTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,518,000
Market Cap $14.9M
Description
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...

Get notified when there are updates to the investment portfolio of Redmond Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmond Asset Management, LLC with notifications on news.